Overview SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg Status: Completed Trial end date: 2012-09-01 Target enrollment: Participant gender: Summary The aim of this study is to evaluate the tolerance and effect on unmedicated subjects with elevated IOP. Phase: Phase 1/Phase 2 Details Lead Sponsor: Sylentis, S.A.